| NASDAQ (usa) |
|
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
| DAX (german) |
|
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Hunan Jingfeng Pharmaceutical Co.Ltd (SHE: 000908)
000908 Technical Analysis
4
| As on 11th Dec 2025 000908 STOCK Price closed @ 7.70 and we RECOMMEND Buy for LONG-TERM with Stoploss of 5.36 & Strong Buy for SHORT-TERM with Stoploss of 4.56 we also expect STOCK to react on Following IMPORTANT LEVELS. |
000908STOCK Price
| Open | 7.70 | Change | Price | % |
| High | 7.70 | 1 Day | 0.37 | 5.05 |
| Low | 7.34 | 1 Week | -0.97 | -11.19 |
| Close | 7.70 | 1 Month | 0.41 | 5.62 |
| Volume | 25524884 | 1 Year | 2.91 | 60.75 |
| 52 Week High 9.23 | 52 Week Low 3.85 | ||||
SHE China Most Active Stocks
| 002217 | 3.39 | -8.63% |
| 002157 | 3.45 | 9.87% |
| 000725 | 4.11 | -1.67% |
| 000002 | 5.07 | -3.43% |
| 000564 | 2.53 | -4.89% |
| 000592 | 12.85 | 2.88% |
| 300058 | 8.74 | -4.90% |
| 002607 | 2.66 | 0.38% |
| 002413 | 9.35 | 2.97% |
| 000063 | 37.82 | -10.00% |
SHE China Top Gainers Stocks
SHE China Top Losers Stocks
| 000908 Daily Charts |
000908 Intraday Charts |
Whats New @ Bazaartrend |
000908 Free Analysis |
|
|
000908 Important Levels Intraday
| RESISTANCE | 8.39 |
| RESISTANCE | 8.17 |
| RESISTANCE | 8.03 |
| RESISTANCE | 7.90 |
| SUPPORT | 7.50 |
| SUPPORT | 7.37 |
| SUPPORT | 7.23 |
| SUPPORT | 7.01 |
000908 Forecast December 2025
| 4th UP Forecast | 9.82 |
| 3rd UP Forecast | 9.14 |
| 2nd UP Forecast | 8.72 |
| 1st UP Forecast | 8.3 |
| 1st DOWN Forecast | 7.1 |
| 2nd DOWN Forecast | 6.68 |
| 3rd DOWN Forecast | 6.26 |
| 4th DOWN Forecast | 5.58 |
000908 Weekly Forecast
| 4th UP Forecast | 9.32 |
| 3rd UP Forecast | 8.80 |
| 2nd UP Forecast | 8.48 |
| 1st UP Forecast | 8.16 |
| 1st DOWN Forecast | 7.24 |
| 2nd DOWN Forecast | 6.92 |
| 3rd DOWN Forecast | 6.60 |
| 4th DOWN Forecast | 6.08 |
000908 Forecast2025
| 4th UP Forecast | 18.55 |
| 3rd UP Forecast | 15.07 |
| 2nd UP Forecast | 12.92 |
| 1st UP Forecast | 10.77 |
| 1st DOWN Forecast | 4.63 |
| 2nd DOWN Forecast | 2.48 |
| 3rd DOWN Forecast | 0.33 |
| 4th DOWN Forecast | -3.15 |
Hunan Jingfeng Pharmaceutical Co.Ltd ( SHE China Symbol : 000908 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
000908 Other Details
| Segment | EQ | |
| Market Capital | 3211175168.00 | |
| Sector | Healthcare | |
| Industry | Drug Manufacturers-General | |
| Offical website | > echo $website ; ?> | |
000908 Address
![]() |
||
000908 Latest News
000908 Business Profile
Hunan Jingfeng Pharmaceutical Co.,Ltd. manufactures and sells chemical drugs and biological agents. The company's principal product is sodium hyaluronate injection for use in orthopedics and surgery applications. It also offers ophthalmology and API products, as well as engages in the research and development of anti-tumor, cancer, and cardiovascular drugs; and provides CMO services covering cell culture, microbial fermentation, biologics, and pre-filled platforms. The company was founded in 2003 and is headquartered in Shanghai, China. Address: China Resources Times Square, Shanghai, China, 200120
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service

